Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px
Document › Details

Molecular Health GmbH. (11/13/15). "Press Release: Molecular Health Opens Berlin Office to Support Growing Demand for Digital Health Solutions". Heidelberg & Boston, MA.

Region Region Berlin
  Country Germany
Organisations Organisation Molecular Health GmbH (MolecularHealth)
  Group Molecular Health (Group)
  Organisation 2 Molecular Health GmbH, Berlin office
  Group Molecular Health (Group)
Products Product digital health
  Product 2 genomic software tools
Persons Person von Bohlen, Friedrich (Dievini before Lion Bioscience)
  Person 2 Völker, Lutz (Molecular Health 201511 CEO)
     


Company strengthens relationships with policy makers and patient advocacy groups


Molecular Health, a leader in cloud-based healthcare decision support technology to enable evidence-based treatment decisions and improved outcomes, today announced that the company has opened an office in Berlin, Germany to accelerate the growing European demand for its suite of digital health solutions.

Located on Friedrichstrasse in downtown Berlin close to the government district, the new office reflects Molecular Health´s continued corporate growth and will enable the company to further strengthen its relationships with policy makers and patient advocacy groups in Germany.

Renowned guests at the opening event on November 12, 2015 included Prof. Dr. Christiane Woopen, Chairman of the German Ethics Council and an expert in genome analysis, and Dr. Friedrich von Bohlen, Founder and Chairman of the Board of Molecular Health.

Lutz Voelker, CEO of Molecular Health, said, “The opening of our Berlin office is another important milestone in our global commercial strategy. Our presence in Berlin allows continued interactions with key stakeholders across healthcare and the regulatory landscape in Germany. As patient advocacy organizations, healthcare policy makers and payers continue to adopt digital health solutions, we are ideally positioned to accelerate technology-driven healthcare decision making in Germany.”


About Molecular Health

Molecular Health is a leading biomedical company that is transforming molecular data and medical knowledge into actionable clinical information for more efficient and safe targeted therapies for each individual patient. Molecular Health generates individualized analysis and clinical interpretation for evidence-based targeted therapy identification utilizing published medical knowledge in a clinical context. In Europe, Molecular Health has the first registered medical device of its kind for personalized cancer medicine. Molecular Health Inc., headquartered in Boston, MA, with a laboratory and support center in Greater Houston, TX, is a wholly owned subsidiary of Molecular Health GmbH, headquartered in Heidelberg, Germany. To learn more, please visit:

www.molecularhealth.com.


Media Contacts

U.S.:
Mark Rodgers
+1-832-247-3068
mark.rodgers@molecularhealth.com

EU:
Carla Mertens
+49 6221 43851-2275
carla.mertens@molecularhealth.com

   
Record changed: 2017-04-02

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

More documents for Molecular Health (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland German Biotech Days 2019 Würzburg 600x60px




» top